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Purpose—Colorectal cancer (CRC) incidence rates have increased among young adults and have 
decreased among older adults. We re-evaluated these trends using more recent data covering about 
96 % of the United States population.
Methods—Colorectal cancer incidence rates were abstracted from the National Program of 
Cancer Registries and the Surveillance Epidemiology and End Results analytic files for diagnosis 
years 1998–2009. We report rates for young adults (age<50 years) and for older adults (age 50 
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years or older) by four race/ethnicity groupings. We examined CRC incidence rates by stage at 
diagnosis, tumor subsite, and state. We calculated the correlation between state-specific CRC 
incidence and prevalence of colonoscopy reported in the Behavioral Risk Factor Surveillance 
System.
Results—Rectal cancer incidence rates increased from 1998 through 2009 among young non-
Hispanic white adults and young blacks. Among older adults, CRC incidence rates decreased 
among all four race/ethnicity groupings and in all states. The decline was apparent for all stages 
and for all subsites. States with greater decreases in CRC incidence rates had higher colonoscopy 
screening rates.
Conclusion—Rectal cancer is increasing among younger adults, for reasons largely unknown. 
Among older adults, CRC incidence continues to decrease, probably because of increasing uptake 
of colonoscopy screening. Decreases in CRC incidence are correlated with increased use of 
colonoscopy, indicating that CRC may be largely preventable through colonoscopy screening. 
Efforts to increase screening rates in underserved populations would help reduce health disparities 
associated with this type of cancer.
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Introduction
In 2008, the US Preventive Services Task Force (USPSTF) recommended screening for 
colorectal cancer (CRC) in adults beginning at age 50 years and continuing until age 75 
using (1) annual high-sensitivity fecal occult blood testing or (2) sigmoidoscopy every five 
years combined with high-sensitivity fecal occult blood testing every three years or (3) 
colonoscopy every 10 years [1]. These recommendations represented a policy change. In 
2002, the USPSTF recommended CRC screening in all adults aged 50 years or older. The 
updated guidelines do not include routine screening in adults age 75 through 85 and 
recommend against screening in adults older than 85 [1]. The reduction in mortality 
associated with CRC screening is due to the detection and removal of early-stage cancer or 
precancerous lesions [1]. Colonoscopy is a component in any CRC screening program since 
follow-up of positive screening tests requires colonoscopy [1].
The benefits of CRC screening have become evident in national cancer statistics. The CRC 
incidence rates among adults aged 50 years or older have declined in recent years [2]. In 
contrast, CRC incidence rates among young (ages 20–49) non-Hispanic (NH) white men and 
women and Hispanic men increased between 1992 and 2005, while CRC incidence rates 
among young NH black and Asian men and women and Hispanic women remained stable 
[3].
The purpose of this report is to evaluate CRC incidence trends from 1998 to 2009 stratified 
by age (younger than 50 years and 50 years or older), nationally, and by state using 
combined data from the CDC’s National Program for Cancer Registries (NPCR) and the 
National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. 
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While these registries included the entire US population, the CRC incidence data included in 
our analysis covered about 96 % of the population between 1998 and 2009.
Materials and methods
Data were abstracted from a combined NPCR and SEER analytic file using the SEER*Stat 
program, version 8.0.1 [4]. We excluded from analyses data for the years a state did not 
meet the quality standards for publication in the United States Cancer Statistics (USCS) [5]. 
Data were obtained from 45 NPCR state cancer registries, the District of Columbia (DC), 
and from five SEER state cancer registries. The minimum number of years of state data was 
seven (two states), while 40 states had data for the full 12 years. The use of the term, state, 
henceforth refers to the 50 states and the DC. We combined the data from all states for the 
purpose of conducting anatomic subsite and stage-specific analyses and to obtain the overall 
US CRC incidence rates. We also obtained each state-specific overall CRC incidence rate 
for the purpose of state comparisons. Analyses were stratified by age: young adults (<50 
years of age) or older adults (aged 50 years or older). These two age groups were never 
combined.
The rubric CRC included the cecum (International Classification of Diseases for Oncology, 
third edition [6] = C180), appendix (C181), ascending colon (C182), hepatic flexure (C183), 
transverse colon (C184), splenic flexure (C185), descending colon (C186), sigmoid colon 
(C187), large intestine—NOS (C188, C189, C260), rectosigmoid junction (C199), and 
rectum (C209). Anatomic subsite analyses included the proximal colon [cecum, ascending 
colon, hepatic flexure, transverse colon, and splenic flexure], the distal colon [descending 
colon and sigmoid colon], and rectum [rectum and rectosigmoid junction].
Colorectal cancer stage at diagnosis was classified according to the extent of disease [local, 
regional, distant, and unknown] using the SEER 1977 and 2000 staging schemes [7, 8]. 
During the study period, stage coding for cancer was affected by the publication of national 
guidelines for state registries (i.e., SEER 2000) and especially by the introduction of 
collaborative staging (CS) in 2004 [9, 10]. Thus, to maintain comparability of CRC stage 
coding across the study period (1998–2009), we used a “standardized” staging system we 
developed [11].
We classified race/ethnicity for the US analyses as non-Hispanic whites (NHWs), Hispanic 
whites, blacks (regardless of Hispanic ethnicity), and Asians (regardless of Hispanic 
ethnicity), using the classifications available in the NPCR/SEER analytic files. We did not 
include American Indians/Alaska Natives in this analysis because of small numbers. For 
state-specific analyses, we classified race/ ethnicity as whites (NHWs and Hispanic whites) 
and blacks.
We calculated age-standardized CRC incidence rates for younger adults (age <50 years) and 
for older adults (age ≥ 50 years) using the 2000 standard million US age population, 
truncated appropriately for the younger or older age group. We calculated the annual percent 
change (APC) in CRC incidence rates using the formula  where b1 is 
the slope from the weighted regression of the logarithm of the rate on year of diagnosis 
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using the case count as the analytic weight. We displayed a funnel plot of the state APCs in 
CRC incidence rates according to their standard errors to highlight states with high and low 
APCs [12].
We obtained information on sigmoidoscopy/colonoscopy use from the CDC’s Behavioral 
Risk Factor Surveillance System (BRFSS) for the years 1997, 1999, 2002, 2004, 2006, and 
2008 [13]. Respondents aged 50 years or older were asked whether they ever had a 
sigmoidoscopy/colonoscopy. In 1997, the question pertained to sigmoidoscopy/proctoscopy, 
but this year is included in the BRFSS online statistics in the category sigmoidoscopy/
colonoscopy. We regressed the logarithm of the odds (% Yes ÷ % No) of the response on 
year of survey for each state and plotted the slope from these models against the state APC 
in CRC incidence rates. We also obtained the overall % Yes according to state across survey 
years and plotted this variable against the state APC in CRC incidence rates. For brevity, 
sigmoidoscopy/ colonoscopy is referred to as S/C endoscopy henceforth.
Statistical analyses were performed using Stata version 12 [14].
Results
Younger adults (aged <50 years)
Among young NHWs, CRC incidence rates increased during the period 1998 through 2009 
(APC = 1.61 (95 % CI 1.35, 1.87) among men and 1.79 (1.46, 2.11) among women). Overall 
CRC incidence rates did not increase significantly from 1998 through 2009 among young 
blacks, Asians, and Hispanic whites (Table 1).
The increase in CRC cancer incidence from 1998 through 2009 differed by proximal colon, 
distal colon, or rectal subsite (Table 1). Among NHWs, the largest increase was observed for 
rectal cancer and the second largest increase for distal colon. The increases for these two 
subsites were not statistically significantly different from each other, but the increase in 
proximal colon was significantly smaller than was the increase for distal colon and rectal 
cancer. Among young black adults, rectal cancer incidence increased significantly among 
men and women between 1998 and 2009, while proximal colon and distal colon cancer rates 
were stable. The increase in CRC among young NHWs was evident for local, regional, and 
distant stages.
Older adults (aged 50 years or older)
The APCs in CRC incidence according to stage and subsite at diagnosis by race/ethnicity 
and gender are displayed in Table 2. CRC incidence rates declined from 1998 through 2009 
among each of the four race/ethnicity groups. The decline is apparent for all stages, although 
the incidence rate of regional CRC declined most rapidly. The difference in the rate of 
decline of regional CRC compared with the average rate of decline of local and distal CRC 
was statistically significant for blacks, Asians, and Hispanic whites.
The incidence rates of proximal, distal, and rectal CRC significantly decreased from 1998 
through 2009 among each of the four race/ethnicity groups (Table 2, Fig. 1). The rate of 
decline for proximal, distal, and rectal CRC was not statistically significantly different 
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among blacks, Asians, and Hispanic whites. For NHWs, the rate of decline of the incidence 
rate of distal CRC was significantly larger than was the average rate of decline of proximal 
and rectal CRC. Overall CRC incidence rates are highest for blacks, followed by NHWs, 
then Hispanic whites, and are lowest for Asians. The decrease in CRC incidence was largest 
for NHWs (p <0.0001) compared with the other three race/ethnicity groups and about equal 
for the other three race/ethnicity groupings (p >0.20). From 1998 through 2009, CRC annual 
incidence rates among adults aged 50 years or older declined from 210.1/105 to 162.6/105 
among blacks (an 23 % reduction), from 140.2/105 to 107.9/105 among Asians (a 23 % 
reduction), from 157.0/105 to 116.9/105 among Hispanic whites (a 26 % reduction), and 
from 196.5/105 to 132.9/105 among NHWs (a 32 % reduction).
State-based CRC rates among older adults
The APCs for CRC incidence for each of the 50 states and for the District of Columbia are 
displayed in map format for whites in Fig. 2a and for blacks in Fig. 2b. For whites, CRC 
incidence declined in all states, but the decline was not statistically significant for Hawaii. 
The mean APC for NHWs across states was −3.13 (−3.41, −2.86)95 %, while the average 
APC weighted by the inverse variance of the state-specific APCs was −3.02 (−3.10, 
−2.95)95 %.
For blacks, we excluded 11 states from the analysis because they had fewer than 100 CRC 
cases during the study period. Of the 40 remaining states, the CRC incidence rates decreased 
in 38 states, of which 28 were statistically significant. The mean APC for blacks across 
states was −2.29 (−2.76, −1.83)95 %, while the weighted average was −1.94 (−2.12, −1.76). 
The state-level mean difference in the APCs for blacks versus whites was 0.87 (95 % CI 
0.43, 1.31; p = 0.0003) in the 40 states with a 100 or more black CRC cases.
The findings for whites and blacks combined are displayed as a funnel plot in Fig. 3. States 
at the bottom of the figure provide the most precise APCs. States on the left of the figure had 
the largest decreases in CRC incidence. The mean APC was −3.02 (−3.28, −2.75), while the 
weighted average APC was −2.91 (−2.98, −2.84). The APC was below zero for all states, 
and the decrease in CRC incidence was statistically significant for 50 states. The smallest 
decreases in CRC incidence rates were in Hawaii (−0.40), Alabama (−0.54), and North 
Dakota (−1.35); all of their APCs are outside the pseudo 95 % CI, and the APC for Hawaii 
is not statistically significant. The states with the largest decreases in CRC incidence are 
Wisconsin (−4.55), Vermont (−4.47), and Rhode Island (−4.40). States that have better-than-
average decreases in CRC incidence and are considerably outside the pseudo 95 % limits are 
Wisconsin (−4.55), Vermont (−4.47), Rhode Island (−4.40), Maryland (−4.17), and Florida 
(−4.08).
CRC incidence rates and colonoscopy among older adults
The correlation between state-level annual percentage changes in CRC incidence among 
whites and blacks and the average BRFSS self-reported colonoscopy rates across years was 
−0.57 (p <0.0001) (Fig. 4a). That is, states with greater decreases in CRC incidence rates 
during the study period tended to have higher colonoscopy screening rates. Additionally, 
states that experienced greater decreases in CRC incidence rates generally also experienced 
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greater increases in colonoscopy screening rates in BRFSS (correlation between annual 
percentage change in CRC incidence and annual percentage change in colonoscopy rates = 
−0.43; p = 0.002) (Fig. 4b).
Discussion
Our analysis using a large nationally representative dataset shows CRC incidence increased 
from 1998 through 2009 among young NHW adults, extending and expanding the findings 
reported in the SEER 13 registries from 1992 through 2005 [2]. These data indicate that 
CRC incidence rates among young black, Asian, and Hispanic white men and women 
increased from 1998 through 2009, but the increases were small and not statistically 
significant. The increase in CRC incidence rates among the young NHWs was strongest for 
rectal cancer, but evident for distal colon cancer as well. Additionally, we found a 
statistically significant increase in rectal cancer among young black men and women and 
small and non-significant increases among Asians and Hispanic whites. An advantage of the 
national data compared with the SEER registries is that it is possible to evaluate trends 
among minority racial/ethnic groups. In addition, the NPCR data add significantly more data 
from regions and populations in the USA where cancer rates are higher due to differences in 
risk factors such as smoking [15].
The increase in distal colon cancer and rectal cancer incidence among young adults is 
largely unexplained. Siegel et al. [3] suggested that the increased prevalence over the last 
three decades of obesity and type 2 diabetes, which are risk factors for CRC, may partially 
account for the increased CRC incidence rates in young adults. Larsson et al. [16] estimate 
that the rate of CRC increases about 20 % per 5 Unit (kg/m2) increase in body mass index 
(BMI), a standard measure of excess weight. Among NHWs’ ages 20 through 49, mean BMI 
increased from 25.7 in 1998 to 28.1 kg/m2 in 2009 [17] with a corresponding APC of 1.69 
for CRC incidence rates among young NHW adults. Using these statistics, we estimate that 
about 48 % of the increase in CRC incidence among young NHW adults may be due to 
increased BMI. Additionally, we allowed for a 5-year temporal lag in the population BMI 
measurements (25.0 in 1993 to 27.4 kg/m2 in 2004) and for a 10-year lag (24.2 in 1988 and 
25.8 kg/m2 in 1999) and obtained estimates of the increase in CRC due to increased BMI of 
48 % and 31 %, respectively. We note, however, that the attribution of the recent increase in 
CRC incidence rates among the young to increased obesity among them in this ecologic 
analysis is speculative. The prevalence of diabetes among NHW young adults in 1998 was 
1.8 %, while in 2009, it was about 5.2 % [17]. Larsson et al. [18] estimate that the rate of 
CRC is about 30 % higher among diabetics compared with non-diabetics. These statistics 
suggest that the increase in the prevalence of diabetes among young NHWs can explain only 
about 5 % of the increased incidence rate of CRC. Allowance for a five- and 10-year lag 
periods reduces the estimates to 4 % and to 0 %, respectively, reinforcing the notion that an 
increasing prevalence of diabetes is not a cause of the increased rates of CRC in young 
adults. We did not do the corresponding calculation for blacks either for BMI or for diabetes 
since CRC incidence rates increased only 0.38 % per year from 1998 through 2009 among 
young black adults. The observation that diabetes is related both to colon and to rectal 
cancer [18] and the effect of obesity, if anything, is slightly stronger for colon versus rectal 
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cancer [16] detracts from the notion that changes in obesity and diabetes are responsible for 
the increase in the rates of rectal cancer among young adults.
Among older adults, CRC incidence rates declined from 1998 through 2009 among each of 
the four race/ethnicity groups. The decline was highest among NHWs, but statistically 
significant declines were apparent among blacks, Asians, and Hispanic whites. The decline 
was about equal for proximal colon, distal colon, and rectal cancers among blacks, Asians, 
and Hispanic whites and was highest for distal colon cancer among NHWs. For extent of 
disease, the declines in CRC incidence were apparent for all stages among whites, blacks, 
and Hispanic whites with largest declines in regional-stage CRC for all race/ethnicity 
groupings.
With respect to states, it is remarkable that CRC incidence rates declined significantly from 
1998 through 2009 among whites in almost all states and among blacks in 28 of the 40 states 
with sufficient data to analyze. APCs in CRC incidence rates were inversely correlated with 
colonoscopy screening rates as well as with changes in the uptake of colonoscopy screening 
in the period 1997 through 2008.
Naishadham et al. [19] reported a correlation of −0.65 between the percentage change in 
CRC mortality rates between 1990–1994 and 2003–2007 and colon cancer screening rates 
(fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy). Our analysis verifies this 
finding, although an advantage of our approach is that we use incidence rather than mortality 
rates, and we restricted our definition of screening to colonoscopy because it is the most 
commonly used CRC screening test [20]. Data from the 2010 National Health Interview 
Survey (NHIS) indicate that while FOBT use was high among adults with military health 
care insurance (17.5 %), associations with other sociodemographic and health care variables 
were similar as with colonoscopy [20]. Data from the BRFSS demonstrate that the use of 
FOBT among US adults aged 50–75 decreased from 21.1 to 11.8 % from 2002 to 2010 [21]. 
Results from the NHIS show that in 2000, 34 % of US adults aged 50–75 reported getting 
any colorectal test or procedure and 19 % reported getting a colonoscopy; in 2010, 59 % 
reported getting any colorectal test or procedure and 55 % reported getting a colonoscopy 
[22]. While FOBT is effective for the early detection of colorectal cancer and decreases 
colorectal cancer mortality, since the use of FOBT is declining and the use of colonscopy is 
increasing, decreases in colorectal cancer incidence are likely to be due to the increased use 
of colonoscopy. Typically, in cancer screening, it is anticipated that the beneficial effect of 
screening will be reflected in a decline in mortality, not incidence rates. In fact, incidence 
rates are likely to increase just after the initiation of a screening program since some early 
latent cancers will be detected by the screening program. However, colonoscopy is different 
in that its application leads to a reduction in incidence rates (and therefore mortality rates as 
well). The decrease in incidence is apparent for the entire colon/rectum and for all stages. 
Such a pattern probably results from excising pre-malignant lesions throughout the entire 
colon with a corresponding decrease in proximal and distal colon cancers and a general 
decrease across all stages.
Our analysis of colonoscopy screening rates and trends in CRC incidence rates has all the 
limitations of any ecologic analysis. In short, some other temporal factor correlated with 
Austin et al. Page 7













colonoscopy rates may account for the decline in the state CRC incidence rates. Yet, it is 
difficult to imagine how an extraneous factor would cause a decrease in CRC incidence rates 
in older adults given that rectal cancer and distal colon cancer incidence rates have increased 
in young adults. Colonoscopy is the most likely explanation since its use is confined to those 
experiencing the benefit of decreased CRC rates (adults aged 50 years or older), its 
prevalence is sufficiently high (~50 %), and it is biologically plausible that the removal of 
pre-cancerous lesions would result in a decrease in the occurrence of CRC.
In summary, CRC incidence rates, especially distal colon cancer and rectal cancer, have 
increased in recent years among young adults for reasons largely unknown, although some 
of the increase may be explained by increased prevalence of obesity. Among older adults, 
the decline in CRC incidence rates in recent years has been large, widespread across states, 
evident across all race/ ethnic groups, and most likely attributable to increased uptake of 
screening, especially colonoscopy.
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Logarithm of CRC incidence rates by year (1998–2009) and tumor subsite according to race/
ethnicity among adults aged 50 years or older, all states combined
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a APCs in overall CRC incidence rates among whites aged 50 years or older by state. b 
APCs in overall CRC incidence rates among balcks aged 50 years or older by state
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Funnel plot of state-specific APC in overall CRC among adults aged 50 years or older
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a Correlation between state-level change in overall CRC incidence rates and S/C endoscopy 
screening rates among US adults aged 50 years or older. b Correlation between state-level 
change in overall CRC incidence rates and change in S/C endoscopy screening rates among 
US adults aged 50 years or older
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